Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia.

Su, Helen C; Jing, Huie; Zhang, Yu; Casanova, Jean-Laurent

Su, Helen C; Jing, Huie; Zhang, Yu; Casanova, Jean-Laurent.

Afiliación

Su HC; Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH; Bethesda, Maryland, USA; email: hsu@niaid.nih.gov.
Jing H; Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH; Bethesda, Maryland, USA; email: hsu@niaid.nih.gov.
Zhang Y; Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH; Bethesda, Maryland, USA; email: hsu@niaid.nih.gov.
Casanova JL; Howard Hughes Medical Institute and St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.

Annu Rev Immunol ; 41: 561-585, 2023 04 26.

Article en En | MEDLINE | ID: mdl-37126418

Asunto(s)

COVID-19; Interferón Tipo I; Ratones; Humanos; Animales; Interferones/farmacología; SARS-CoV-2

Palabras clave

COVID-19; SARS-CoV-2; anticytokine autoantibodies; human genetics; type I interferon

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Annu Rev Immunol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google